Stock Information

Spyre Therapeutics Inc (SYRE)

Spyre Therapeutics Inc logo
Ticker Symbol: SYRE
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,337.24 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -2.5525
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -31.14%

Key Financials

Financial data not available